StockData
VolitionRx Ltd logo

VolitionRx Ltd (VNRX) stock

VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.19−0.01 (-5.56%)

Close on Nov 17, 2026Market cap $2.58MP/E –Yield –

VolitionRx r&d expenses

Research and development expenses are spending on new products and technology.

VolitionRx's R&D Expenses for the twelve months ending Jun 30, 2026 was $9.41M, down 17.4% year over year. For fiscal 2025 it was $10.08M, down 30.0% from the year before. Over ten years it grew 5.1% a year on average. The highest annual figure on record is $19.55M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$10.08M-30.0%
FY2024Dec 31, 2024$14.41M-26.3%
FY2023Dec 31, 2023$19.55M+27.5%
FY2022Dec 31, 2022$15.33M+17.7%
FY2021Dec 31, 2021$13.02M-10.4%
FY2020Dec 31, 2020$14.53M+40.2%
FY2019Dec 31, 2019$10.36M-5.0%
FY2018Dec 31, 2018$10.91M+35.9%
FY2017Dec 31, 2017$8.03M+1.5%
FY2016Dec 31, 2016$7.90M+29.6%
FY2015Dec 31, 2015$6.10M+50.9%
FY2014Dec 31, 2014$4.04M+61.5%
FY2013Dec 31, 2013$2.50M-9.7%
FY2012Dec 31, 2012$2.77M+82.3%
FY2011Dec 31, 2011$1.52M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.80M-33.8%
Q1 FY2026Mar 31, 2026$2.85M+9.4%
Q4 FY2025Dec 31, 2025$2.47M-4.6%
Q3 FY2025Sep 30, 2025$2.29M-34.2%
Q2 FY2025Jun 30, 2025$2.72M-26.8%
Q1 FY2025Mar 31, 2025$2.61M-43.7%
Q4 FY2024Dec 31, 2024$2.59M-43.1%
Q3 FY2024Sep 30, 2024$3.47M-25.3%
Q2 FY2024Jun 30, 2024$3.72M-31.8%
Q1 FY2024Mar 31, 2024$4.63M-5.6%
Q4 FY2023Dec 31, 2023$4.54M+10.0%
Q3 FY2023Sep 30, 2023$4.65M+16.2%
Q2 FY2023Jun 30, 2023$5.45M+66.2%
Q1 FY2023Mar 31, 2023$4.91M+36.6%
Q4 FY2022Dec 31, 2022$4.13M+25.2%
Q3 FY2022Sep 30, 2022$4.00M+10.8%
Q2 FY2022Jun 30, 2022$3.28M+11.7%
Q1 FY2022Mar 31, 2022$3.59M-7.3%
Q4 FY2021Dec 31, 2021$3.30M-16.8%
Q3 FY2021Sep 30, 2021$3.61M+13.6%
Q2 FY2021Jun 30, 2021$2.94M-16.0%
Q1 FY2021Mar 31, 2021$3.87M-0.6%
Q4 FY2020Dec 31, 2020$3.97M+43.3%
Q3 FY2020Sep 30, 2020$3.18M+20.3%
Q2 FY2020Jun 30, 2020$3.49M+40.9%
Q1 FY2020Mar 31, 2020$3.89M+57.4%
Q4 FY2019Dec 31, 2019$2.77M-9.6%
Q3 FY2019Sep 30, 2019$2.64M-3.5%
Q2 FY2019Jun 30, 2019$2.48M-7.7%
Q1 FY2019Mar 31, 2019$2.47M+2.1%
Q4 FY2018Dec 31, 2018$3.06M+27.1%
Q3 FY2018Sep 30, 2018$2.74M+28.3%
Q2 FY2018Jun 30, 2018$2.69M+48.6%
Q1 FY2018Mar 31, 2018$2.42M+45.2%
Q4 FY2017Dec 31, 2017$2.41M-11.6%
Q3 FY2017Sep 30, 2017$2.13M+8.4%
Q2 FY2017Jun 30, 2017$1.81M–
Q1 FY2017Mar 31, 2017$1.67M–
Q4 FY2016Dec 31, 2016$2.72M–
Q3 FY2016Sep 30, 2016$1.97M–

More VolitionRx figures

See a number that looks wrong?